Tag: USANA
USANA Q1 Revenue 2024 Down 8% To $228 Million
May 2, 2024
Key Financial & Operating Results First quarter net sales were $228 million versus $248 million during Q1 2023, and increased 2% sequentially in constant currency. First quarter diluted EPS was $0.86 as compared with $0.95 during ...
Read more
USANA Reports Second Q2 Sales of $238 Million
August 1, 2023
USANA Health Sciences (NYSE: USNA) recently announced its financial results for the second fiscal quarter ending July 1, 2023. The company achieved second quarter net sales of $238 million during this period, compared to $264 million ...
Read more
USANA Plans to Expand Into India
May 7, 2023
USANA Health Sciences, Inc. (NYSE: USNA) recently announced its plans to expand into India in the second half of 2023. Expansion into India increases the Company’s global footprint to 25 markets. “USANA’s expansion into India is ...
Read more
USANA Appoints Jim Brown As CEO
February 14, 2023
USANA Health Sciences, Inc. (NYSE: USNA) announced that consistent with the Company’s planned succession strategy, Kevin Guest, USANA’s Chief Executive Officer (CEO) since 2015 and Chairman of the Board since 2020, will transition to the role ...
Read more
USANA Sales 2022 Down 16% To $999 Million
February 13, 2023
USANA Health Sciences, Inc. announced financial results for its fiscal fourth quarter and full year ended December 31, 2022. Key Financial & Operating Results Fourth quarter net sales were $228 million versus $267 million during the ...
Read more
USANA Acquires Network Marketing Company Oola
November 29, 2022
USANA Health Sciences, Inc. (NYSE: USNA) today announced the acquisition of two companies—Rise Bar and Oola. “The acquisition of these emerging companies is part of USANA’s long-term growth strategy” These emerging companies share USANA’s health and ...
Read more
USANA Q3 Revenue Down 15 % To $233 Million
October 26, 2022
USANA Health Sciences, Inc. announced financial results for its fiscal third quarter ended October 1, 2022. Key Financial & Operating Results: Third quarter net sales were $233 million as compared with $274 million during the third ...
Read more
USANA Q2 Revenue Down 21% To $264 Million
July 27, 2022
USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal second quarter ended July 2, 2022. Second quarter net sales were $264 million as compared with $337 million during the second quarter of ...
Read more
USANA Q2 Preliminary Sales Down 21% To $265 Million
July 10, 2022
USANA Health Sciences, Inc. (NYSE: USNA) today announced preliminary results for the second quarter ended July 2, 2022, and provided an updated outlook for fiscal year 2022. The Company anticipates that second quarter 2022 net sales ...
Read more
USANA Revenue 2021 Up %% To $1.186 Billion
February 9, 2022
USANA Health Sciences, Inc. (NYSE: USNA) announced financial results for its full year and fiscal fourth quarter ended January 1, 2022. Key Financial & Operating Highlights Fiscal year 2021 net sales grew 5% to $1.186 billion. ...
Read more
USANA Honored With 3 Prestigious Awards
November 18, 2021
USANA, a leader in cellular nutrition, is proud to announce three major awards won this past month. During the 2021 Direct Selling Association (DSA) Engage Conference, USANA received the Product Innovation award for its Mood and ...
Read more
USANA Q3 Revenue Down 8% To $274 Million
October 28, 2021
USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal third quarter ended October 2, 2021, which were modestly ahead of the preliminary outlook the Company provided on September 16, 2021. Key Financial ...
Read more